% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zare:1005158,
author = {Zare, Iman and Yaraki, Mohammad Tavakkoli and Speranza,
Giorgio and Najafabadi, Alireza Hassani and
Shourangiz-Haghighi, Alireza and Nik, Amirala Bakhshian and
Manshian, Bella B. and Saraiva, Cláudia and Soenen, Stefaan
J. and Kogan, Marcelo J. and Lee, Jee Woong and Apollo,
Nicholas V. and Bernardino, Liliana and Araya, Eyleen and
Mayer, Dirk and Mao, Guangzhao and Hamblin, Michael R.},
title = {{G}old nanostructures: synthesis, properties, and
neurological applications},
journal = {Chemical Society reviews},
volume = {51},
issn = {0306-0012},
address = {London},
publisher = {Soc.},
reportid = {FZJ-2023-01346},
pages = {2601-2680},
year = {2022},
note = {Bitte Post-print ergänzen},
abstract = {Recent advances in technology are expected to increase our
current understanding of neuroscience. Nanotechnology and
nanomaterials can alter and control neural functionality in
both in vitro and in vivo experimental setups. The
intersection between neuroscience and nanoscience may
generate long-term neural interfaces adapted at the
molecular level. Owing to their intrinsic physicochemical
characteristics, gold nanostructures (GNSs) have received
much attention in neuroscience, especially for combined
diagnostic and therapeutic (theragnostic) purposes. GNSs
have been successfully employed to stimulate and monitor
neurophysiological signals. Hence, GNSs could provide a
promising solution for the regeneration and recovery of
neural tissue, novel neuroprotective strategies, and
integrated implantable materials. This review covers the
broad range of neurological applications of GNS-based
materials to improve clinical diagnosis and therapy.
Sub-topics include neurotoxicity, targeted delivery of
therapeutics to the central nervous system (CNS),
neurochemical sensing, neuromodulation, neuroimaging,
neurotherapy, tissue engineering, and neural regeneration.
It focuses on core concepts of GNSs in neurology, to
circumvent the limitations and significant obstacles of
innovative approaches in neurobiology and neurochemistry,
including theragnostics. We will discuss recent advances in
the use of GNSs to overcome current bottlenecks and tackle
technical and conceptual challenges.},
cin = {IBI-3},
ddc = {540},
cid = {I:(DE-Juel1)IBI-3-20200312},
pnm = {5241 - Molecular Information Processing in Cellular Systems
(POF4-524)},
pid = {G:(DE-HGF)POF4-5241},
typ = {PUB:(DE-HGF)16},
pubmed = {35234776},
UT = {WOS:000763005100001},
doi = {10.1039/D1CS01111A},
url = {https://juser.fz-juelich.de/record/1005158},
}